Ardana Bioscience Ltd   Report issue

For profit Phase 3
Founded: Edinburgh United Kingdom (2000)
Status: Acquired by AEterna Zentaris (2009)

Organization Overview

First Clinical Trial
2005
NCT00597051
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

testosterone (delatestryl) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypogonadism (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 1